First AD

Second AD

OncLive News Network®

® video programs provide lively discussions, insights, and expert perspectives on important issues facing today’s cancer care professionals. One variation of the program, titled, 

, comprises live virtual or on-site premium reporting for oncologists as it covers the latest news and information coming out of the largest annual oncology conferences. 

Gastrointestinal Cancer

The OncLive Gastrointestinal Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of gastrointestinal (GI) cancers, including hepatocellular carcinoma, gastric cancer, pancreatic cancer, colorectal cancer, cholangiocarcinoma, esophageal cancer, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in GI cancers.

Gaining Ground: Expanding Options for Advanced HCC

Ghassan Abou-Alfa, MD, Robert Lewandowski, MD, FSIR, and Amit Singal, MD discuss potential novel combination therapies including immune checkpoint inhibitors plus tyrosine kinase inhibitors plus local-regional therapeutic strategies. 

Novel Strategies: Combining Systemic and Local Therapies

Overview of Hepatocellular Carcinoma Risk Factors

Review of Curative Treatment Strategies for HCC

Child-Pugh Scoring System and Liver Function Assessment

Therapy for Locally Advanced HCC

The Advent of Systemic Therapy for HCC

Immune Checkpoint Inhibitors in HCC

Combination Therapy with Immune Checkpoint Inhibitors for HCC

IMbrave-150 and HIMALAYA: Clinical Trials of Immune Checkpoint Inhibitor Combinations in HCC

Immune Checkpoint Inhibitors and Their Effects on Liver Function

Real-World Evidence on Use of Immune Checkpoint Inhibitor Combinations and Clinical Trial Endpoints

HCC International Clinical Trials